MG

MARTIN GOLD

CAPITOL COUNSEL LLC · Washington, DC · registered since 2024
Registered · LDAActive

Background

Government experience
Floor Advisor & Counsel
Senate Majority Leader Bill Frist.
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

Medicare Coverage and Reimbursement issues, including issues related to the Medicare Part B and D Coverage. Issues related to drug pricing.
Medicare/Medicaid · 2024 Q3
Package Inserts/E-Labeling Issues (H.R. 1503 Prescription Information Modernization Act of 2023). Issues related to the Vaccine Injury Compensation Program.
Health Issues · 2024 Q3
Health care reform including implementation of the Affordable Care Act. Monitor implementation of the No Surprises Act.
Health Issues · 2024 Q3
Recovery audit contractor reform. Medicare regulatory reform, including Medicare physician fee schedule and sequestration relief and payment reforms, including Medicare physician payment provisions in: (1) S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, Sec. 403 to extend work geographic index floor under Medicare; Sec. 404 to extend incentive payments for participation in eligible alternative payment models; and Sec. 407 to increase support for physicians and other professionals in adjusting to Medicare payment changes; (2) H.R. 6545, the Physician Fee Schedule Update and Improvements Act, including provisions to increase the work geographic index, increase the Medicare physician fee schedule conversion factor and extend and modify incentive payments for participation in eligible alternative payment models; and (3) H.R. 4366, the Consolidated Appropriations Act, 2024, P.L. 118-42: Sec. 304, Extending Incentive Payments for Participation in Eligible Alternative Payment Models; and Sec. 305, Temporary Payment Increase under the Medicare Physician Fee Schedule to Account for Exceptional Circumstances and Atypical Timing of Enactment. Network adequacy oversight, including Medicare Advantage plan provider directory accuracy issues, including provisions in S. 3430, the Better Mental Health Care, Lower Cost Drugs, and Extenders Act of 2023, in Sec. 109, to require MA plans to maintain accurate provider directories on a public website. Medicare accountable care organizations. Electronic health record interoperability and vendor accountability. Medicare Parts C and D prior authorization reforms, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Physician-led hospital barriers, including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act, and H.R. 9001, the Physician Led and Rural Access to Quality Care Act, to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor: (1) implementation of provisions in the Inflation Reduction Act of 2022 (P.L. 117-169), Subtitle B, Part 1, sec. (b), to modify Medicare Part B reimbursement by application of Maximum Fair Prices and Conforming Amendments, to selected Medicare Part B covered drugs; and (2) CMMI Medicare Part B drug demonstrations, including the Most Favored Nation demonstration.
Medicare/Medicaid · 2024 Q3
Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 977/S. 470, the Patient Access to Higher Quality Care Act; and in H.R. 9001, the Physician Led and Rural Access to Quality Care Act, to revise certain physician self-referral exemptions relating to physician-owned hospitals in rural areas; and related issues regarding hospital competition and consolidation. Center for Medicare & Medicaid Innovation demonstration to expand patient access to physician-led hospitals. Reform Medicare Advantage prior authorization, including related provisions in: H.R. 4968, the GOLD Card Act; H.R. 4822, the Health Care Price Transparency Act; H.R. 5378, the Lower Costs, More Transparency Act; and S. 4518/S. 4532/H.R. 8702, to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. Advocacy related to H.R. 8246, Second Chances for Rural Hospitals Act, and access to physician-led entities.
Medicare/Medicaid · 2024 Q3
Medicare quality standards for hospitals and transplant programs. Education on antibiotic resistance, antibiotic stewardship and related Medicare quality standards.
Medicare/Medicaid · 2024 Q3

Clients

2024 · 4 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
2024 · 3 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 2 filings
$██,███ / qtrUnlock

Filing history

2024 Q3
MERCK & COMPANY, INC.
Q3lda.gov →
2024 Q3
JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS
Q3lda.gov →
2024 Q3
AMERICAN ACADEMY OF OPHTHALMOLOGY
Q3lda.gov →
2024 Q3
HEALTHCARE LEADERSHIP COUNCIL
Q3lda.gov →
2024 Q3
GENENTECH
Q3lda.gov →
2024 Q3
PHYSICIANS ADVOCACY INSTITUTE
Q3lda.gov →
2024 Q3
PHYSICIAN-LED HEALTHCARE FOR AMERICA (FORMERLY PHYSICIAN HOSPITALS OF AMERICA)
Q3lda.gov →
2024 Q3
AMERICAN ACADEMY OF DERMATOLOGY
Q3lda.gov →
2024 Q3
ZAI LAB (US) LLC
Q3lda.gov →
2024 Q3
CASTLE HARLAN, INC.
Q3lda.gov →
2024 Q3
FRANKLIN TEMPLETON FUNDS
Q3lda.gov →
2024 Q3
AUTOS DRIVE AMERICA
Q3lda.gov →
Showing recent filings · full history on lda.gov